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The pannexins (Panxs) are a family of chordate proteins homologous to the invertebrate
gap junction forming proteins named innexins. Three distinct Panx paralogs (Panx1,
Panx2, and Panx3) are shared among the major vertebrate phyla, but they appear to
have suppressed (or even lost) their ability to directly couple adjacent cells. Connecting
the intracellular and extracellular compartments is now widely accepted as Panx’s
primary function, facilitating the passive movement of ions and small molecules along
electrochemical gradients. The tissue distribution of the Panxs ranges from pervasive
to very restricted, depending on the paralog, and are often cell type-specific and/or
developmentally regulated within any given tissue. In recent years, Panxs have been
implicated in an assortment of physiological and pathophysiological processes, particularly
with respect to ATP signaling and inflammation, and they are now considered to be a
major player in extracellular purinergic communication. The following is a comprehensive
review of the Panx literature, exploring the historical events leading up to their discovery,
outlining our current understanding of their biochemistry, and describing the importance
of these proteins in health and disease.
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INTRODUCTION
In 1959, Edwin Furshpan and David Potter observed action
potentials propagating through the crayfish giant motor synapse
with a delay of 0.1ms, or about an order of magnitude faster than
synaptic delays previously recorded. They also demonstrated that
hyperpolarization of the post-synaptic fiber could “leak” back-
wards into the pre-synaptic fiber (Furshpan and Potter, 1959).
These observations did not adhere to the canonical view of the
synapse, whereby action potentials were understood to prop-
agate unidirectionally via chemical intermediaries (Dale et al.,
1936). The authors postulated a “synaptic rectifier” directly link-
ing the cells, leading to the eventual discovery of intercellu-
lar gap junctions. These large aqueous pores span the plasma
membranes of adjacent cells, creating a cytoplasmic syncytium
through which ions and small molecules can rapidly diffuse.
There are two large families of unrelated (yet structurally conver-
gent) transmembrane proteins within theMetazoa that oligomer-
ize into gap junctions, and these have been named the connexins
(Cxs) and innexins (Inxs) (Panchin, 2005). The Cxs are found
exclusively in chordates and have extensive physiological rele-
vance; not only do Cxs act as junctional pipelines between cells,
but their cytoplasmic components are also the site of numer-
ous protein-protein interactions (Harris and Locke, 2008). Inxs
appear to have evolved during the early days of animal mul-
ticellularity, so they are found throughout almost all branches
of the Metazoa, and they too influence a diverse array of phys-
iological processes. The following review will focus heavily on
what is currently known about the chordate members of the
Inx superfamily, which are more commonly known as pannexins
(Panxs).
INNEXINS
Following the original biophysical recording of gap junctions
between arthropod neurons (Furshpan and Potter, 1959),
subsequent studies found electrically equivalent features in other
diverse metazoans, including the earthworm (Wilson, 1961),
leech (Eckert, 1963), fish (Bennett et al., 1963), and mouse (Penn,
1966). The first Cx cDNAs were cloned in 1986 from mammalian
liver samples (Kumar and Gilula, 1986; Paul, 1986) and, once
identified, they were assumed to be the sole gap junction form-
ing proteins, conserved throughout the animal kingdom. This
assumption proved to be incorrect, however, as Cxs are actually
exclusive to the chordate lineage (Panchin, 2005). The Inxs are a
completely unrelated family of proteins responsible for forming
gap junctions within the myriad invertebrata, with surprisingly
similar functional and structural properties to the Cxs given their
ancestral independence.
DISCOVERY
Throughout the decade following the first identification of
mammalian Cx genes, homologous invertebrate genes remained
strangely elusive. In 1994, Thomas Barns proposed that a small
collection of genes present in the worm and fly might represent
a new class of gap junctions; while they lacked any discernable
sequence similarity to the Cxs, they did code for proteins with
predicted structural similarities (Barnes, 1994). He named the
group “OPUS” as an acronym for the genes ogre, Pas, unc-7,
and shakB, which were those identified in his study. When
shakB was later exogenously expressed in paired oocytes, it was,
indeed, shown to encode a gap junction protein (Phelan et al.,
1998b). The OPUS nomenclature was subsequently discarded
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as confusing because Pas and shakB are different alleles of the
same gene, and “OPUS” fails to impart any sense of function to
the group. The name of these genes was instead replaced with
“invertebrate analogs of the connexins”—or, more simply, innex-
ins (Phelan et al., 1998a). In the course of proposing this new
name, Pauline Phelan mused over the fact that more than 90%
of the C. elegans genome had been analyzed with no obvious sign
of a Cx sequence (Phelan et al., 1998a). She postulated that the
sequences were probably not present at all, and so the hunt for
Cxs in worms and flies quietly came to an end. In the interven-
ing years, the volume of genome sequencing data has expanded
exponentially, and still there is no definitive sign of connexins
outside the phylum Chordata, so it seems quite likely that if the
Cx and Inx families are derived from an ancient gene duplica-
tion, their sequences have since diverged beyond our ability to
infer that homology (Yen and Saier, 2007; Abascal and Zardoya,
2013). There are eight Inx genes in the genome of the arthropod
D. melanogaster (Stebbings et al., 2002; Bauer et al., 2005), 25 in
the nematode C. elegans (Altun et al., 2009), and 21 in the annelid
H. verbana (Kandarian et al., 2012), with many more identified
throughout the various metazoan clades (Yen and Saier, 2007).
The protein products from all of these genes are clearly homolo-
gous, apparently originating from a single gene that would have
been present in the ancestral species at the base of the Metazoa
some 600 million years ago (Yen and Saier, 2007).
STRUCTURE AND FUNCTION
Inx proteins are predicted to have four transmembrane domains,
one intracellular and two extracellular loops, and cytoplasmic C-
and N-terminal tails (Barnes, 1994). There are two highly con-
served cysteine residues in both of the extracellular loops (Yen
and Saier, 2007), which are likely under positive selection for
proper channel formation and function (Bunse et al., 2011). Inx
monomers are thought to oligomerize into hexameric pore struc-
tures (known as “innexons”) that loosely aggregate at points of
very close cell-to-cell contact (Tazuke et al., 2002; Lehmann et al.,
2006; Oshima et al., 2013). This may allow them to behave in an
analogous fashion to Cxs, with a hexamer from one cell “dock-
ing” with another on the adjacent cell, thus forming intercellular
gap junctions (Phelan et al., 1998a). Innexons can be constructed
from a single (“homomeric”) isotype or multiple (“heteromeric”)
isotypes (Stebbings et al., 2000), and docking between innex-
ons can be “homotypic” or “heterotypic,” depending on whether
each half is constructed from the same isotype or not (Wu et al.,
2011). In terms of pore activity, representative Inxs from fly,
nematode, and leech have been shown to form highly conduc-
tive, non-specific, transjunctional voltage-sensitive intercellular
channels typical of a chordate gap junction (Phelan et al., 1998a;
Landesman et al., 1999; Stebbings et al., 2000; Bao et al., 2007;
DePriest et al., 2011). Several properties set this group apart,
however, from what is currently known of Cx-based channels.
For example, transjunctional voltage (Vj) is understood to have
a gating effect on Cx based channels irrespective of the isotype
involved (González et al., 2007), while gap junctions consisting
of H. medicinalis inx1 (leech) are completely insensitive to Vj
(Dykes et al., 2004); D. melanogaster inx2 is dependent upon
inx3 as a carrier for proper localization to the plasma membrane
(Lehmann et al., 2006); and, although not yet shown conclusively,
it is thought that some of the Inxs in the C. elegans reproduc-
tive system do not create gap junctions at all, perhaps in favor of
forming functional innexons called “hemichannels” (Altun et al.,
2009). Very few Inx structural features have been explored exper-
imentally, but tryptophan scanning of D. melanogaster inx8 has
recently shown residues H27, T31, L35, and S39 (all in the first
transmembrane domain) to be positioned along one face of an
α-helix that is likely involved in a helix-helix interaction neces-
sary for channel function (DePriest et al., 2011). Further, negative
stain electron microscopy indicates that the C. elegans INX-6
channel has a diameter of ∼140 Å (Oshima et al., 2013).
Broad surveys of Inxs in D. melanogaster and C. elegans show
complex expression patterns throughout embryogenesis and in
adult tissues, often exhibiting isotype overlap (Stebbings et al.,
2002; Altun et al., 2009). Disrupting these normal expression
patterns can have harmful consequences; for instance, Inx7 is nec-
essary for proper axon guidance in the peripheral nervous system
of the D. melanogaster embryo (Ostrowski et al., 2008), and in
conjunction with Inx6, is also required for long term memory
formation (Wu et al., 2011). In the worm, phenotypes associated
with Inx disruption include the eat-5, and unc-7/unc-9 mutants
(three of the earliest observed, and the only C. elegans Inx genes
to not conform to the standard naming scheme), which result
in desynchronization of pharyngeal muscle contractions (Starich
et al., 1996), and severe impairment of forward movement along
with egg-retention, respectively (Starich et al., 1993; Barnes and
Hekimi, 1997).
PANNEXINS
As discussed above, the Cxs are chordate-specific, while inver-
tebrates utilize Inxs to form intercellular gap junctions. It so
happens that Inxs are also expressed alongside Cxs in chordates,
but instead of competing with the Cxs as a redundant class of gap
junction proteins, this family—collectively known as the pannex-
ins (Panxs)—primarily oligomerize into distinct aqueous pores
between the intracellular and extracellular space. Considerable
attention has been focused on the biochemical and functional
properties of Panxs since they were first reported in 2000, and
much of the literature pertaining to this work will be reviewed
here.
DISCOVERY
Yuri Panchin was the first to report how extensively the Inx
genes have radiated throughout the metazoans by identify-
ing homologs in disparate protostomal phyla (Platyhelminthes,
Nematoda, Arthropoda, and Mollusca), as well as in the human
genome (Panchin et al., 2000). In light of this Inx diversity,
and especially because of their presence in non-invertebrates,
Panchin argued that the existing naming convention was not
appropriate. He suggested that this family of genes be re-branded
as “pannexin,” because the Latin prefix “pan,” meaning “all,”
would better represent the phylogenetic range in which they have
been identified (Panchin et al., 2000). Unlike the switch from
OPUS, the community was already becoming accustomed to the
“Innexin” nomenclature, and it has remained largely unchanged
when referring to invertebrate gap junction genes. Even so,
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the new name has been adopted in the case of chordate Inx
homologs, and from lancelet to man these genes are known as
pannexins.
The initial discovery of mammalian Panxs was achieved by
performing BLASTP and PSI-BLAST searches against GenBank,
using Inx sequences from several different invertebrate phyla as
the query (Panchin et al., 2000); subsequent studies have since
applied further statistical methods to confirm homology between
Inxs and Panxs (Baranova et al., 2004; Phelan, 2005; Yen and
Saier, 2007; Fushiki et al., 2010). As with the Inx genes fromworm
and fly, significant conservation of primary amino acid sequence
is not seen between the Cxs and Panxs, despite having similar
structural topologies (Fushiki et al., 2010). There has, however,
been a recent discovery of another protein that may share ances-
try with Panxs—specifically, the leucine-rich repeat containing
8 (LRRC8). It appears that the entire transmembrane region of
an ancient Panx gene may have fused with a leucine-rich repeat
(LRR)-containing domain, with the LRR taking on the role of a
new C-terminal tail (Abascal and Zardoya, 2012). To date, there
have been no biophysical analyses of this unique protein, but
if it represents yet another large plasma membrane channel, it
could explain some of the conflicting reports regarding perme-
ability within the Panx literature that are discussed in subsequent
sections of this review.
BIOCHEMICAL PROPERTIES
Panxs form low-resistance channels at the plasma membrane,
with multiple distinct gating mechanisms. Post-translational
modifications to the monomeric peptides are critical for proper
intracellular localization and channel function, and a rapidly
growing list of interacting proteins implies a complex and mul-
tifunctional role for Panxs in cellular processes.
Isotypes
Vertebrate Panx genes have been grouped into three broad iso-
types, and the products of these genes have been designated
Panx1, Panx2, and Panx3. Duplication events that occurred prior
to the radiation of the subphylum Vertebrata are responsible for
creating these Panx paralogs and, as a result, all three are ortholo-
gous across taxa [e.g., Panx2 in Xenopus is equivalent to Panx2
in human (Abascal and Zardoya, 2013)]. Sequence alignments
indicate that Panx orthologs share an average of >70% identity
and>80% similarity at the amino acid level (Table 1). Panx1 and
Panx3 are also relatively well-conserved, sharing ∼60% identity
and ∼75% similarity between paralogs, but Panx2 is significantly
more divergent (Table 2). Several splice variants have been pre-
dicted for Panx1 and Panx2, with experimental evidence for at
least three different Panx1 isoforms in rat (Baranova et al., 2004;
Li et al., 2011b; Turmel et al., 2011), and at least two Panx2 iso-
forms in fish (Zoidl et al., 2008). The teleost fishes also have a
fourth Panx paralog, retained as two “ohnologs” of Panx1 fol-
lowing a whole genome duplication event ∼350 million years
ago (Bond et al., 2012). This duplication presents an interesting
opportunity to assess the plasticity of Panx1 when evolutionary
pressures are relaxed; indeed, the two paralogs are already known
to have diverged in terms of both transcriptional regulation and
channel activity (Bond et al., 2012; Kurtenbach et al., 2013).
Table 1 | Amino acid conservation of Panx orthologs.
Panx1 Panx2 Panx3
Identity 73.5 ± 3.0% 71.3 ± 4.9% 75.5 ± 5.9%
Similarity 82.6 ± 3.0% 80.0 ± 4.4% 85.2 ± 4.4%
To calculate percent conservation of a given ortholog pair (e.g., between mouse
and chicken Panx1), a pairwise global alignment was first constructed. “Identity”
is defined as an exact match between two aligned residues, and “similarity” indi-
cates positions in an alignment where conservative substitutions are observed
(i.e., a score of greater than zero using the BLOSUM45 substitution matrix). The
values presented represent average conservation (plus or minus one standard
deviation) of all possible combinatorial alignments among Panx orthologs from
M. musculus, G. gallus, X. tropicalis, L. chalumnae, and D. rerio.
Table 2 | Amino acid conservation of Panx paralogs.
Panx1/Panx2 Panx1/Panx3 Panx2/Panx3
Identity 24.9 ± 2.5% 62.4 ± 3.2% 25.9 ± 1.9%
Similarity 37.0 ± 2.0% 74.2 ± 3.0% 37.0 ± 2.6%
To calculate percent conservation of a given paralog pair (e.g., between mouse
Panx1 and mouse Panx2), a pairwise global alignment was first constructed.
“Identity” is defined as an exact match between two aligned residues, and “sim-
ilarity” indicates positions in an alignment where conservative substitutions are
observed (i.e., a score of greater than zero using the BLOSUM45 substitution
matrix). The values presented represent average conservation (plus or minus
one standard deviation) of all possible combinatorial alignments among Panx
paralogs from M. musculus, G. gallus, X. tropicalis, L. chalumnae, and D. rerio.
Structure
Secondary structure and hydrophobicity prediction algorithms
indicate that the gross topology of Panx conforms to that of
the Cx and Inx superfamilies, which includes four transmem-
brane domains with cytoplasmic C- and N-termini (Figure 1).
Site-directed mutagenesis experiments have demonstrated that
four conserved extracellular cysteine residues are required for
functional Panx1 channel formation (Ambrosi et al., 2010; Wang
and Dahl, 2010; Bunse et al., 2011). Of the other conserved
Panx1 cysteines, converting the intracellular residue C346 or the
transmembrane residue C40 to serine results in a constitutively
open channel that rapidly degrades plasma membrane poten-
tials, leading to cell death (Bunse et al., 2010, 2011; Wang and
Dahl, 2010). On the other hand, replacing the same residues
with hydrophobic alanine is non-toxic to transfected cells, so this
substitution probably does not result in a constitutively open
channel (Lohman et al., 2012b). Feng Qiu systematically modi-
fied 81 of the 84 extracellular Panx1 residues to alanine, one at a
time, followed by careful electrophysiological characterization of
the mutant proteins’ ability to form channels (Qiu et al., 2012).
Of the mutants created, 24 ablated voltage gated channel activity;
how each mutation altered channel activity, be it through changes
in folding, trafficking, or direct channel blockage, was outside
the scope of that particular report however. To gain a better
understanding of the actual Panx1 pore structure, the substituted-
cysteine accessibility method and electron microscopy have both
been used, and it appears that residues 3–7, 10, and 12 from
the N-terminus, residues 58–62 from the first transmembrane
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FIGURE 1 | TopologyofCxs, Inxs, andPanxs. Thepredicted arrangement of
these proteins within a membrane has been reported on multiple occasions
(Hua et al., 2003; Panchin, 2005; Barbe et al., 2006; Magie and Martindale,
2008). To generate the predictions shown here, multiple pairwise alignments
were calculated with the E-INS-i algorithm of MAFFT (Katoh and Standley,
2013) using (A) all 21 human Cxs, (B) 25 C. elegans Inxs, and (C–E) the three
Chordate Panx isotypes using protein sequences frommouse, chicken,
Xenopus, coelacanth, and Danio. Transmembrane (TM) regions and ER
integration orientation were predicted with the OCTOPUS algorithm (Viklund
and Elofsson, 2008), using the consensus sequences from each multiple
alignment as input. All of the proteins have compelling support for 4 TM
domains (blue), while the “inside-preference” (orange; based on clustering of
positively charged and polar residues) assigned to the N-terminus and second
loop strongly suggests that the termini are cytoplasmic. The topologies of
each consensus sequence are shown to scale, with relative positions of
extracellular loop cysteines and glycosylated asparagines indicated.
domain, and residues 414–426 from the extreme C-terminus con-
stitute the hydrophilic pore lining moieties (Wang and Dahl,
2010), with the outer entrance of the pore estimated at a diam-
eter of ∼17–21 Å (∼29.5–30.5 Å in the case of Panx2) (Ambrosi
et al., 2010).
Oligomerization
Panxs were shown to form channels very soon after they were
first discovered, so it was assumed that the monomeric pro-
tein oligomerized into a hexameric structure analogous to the
connexon (Bruzzone et al., 2003). Electron microscopy of cell
membranes expressing Panx1 or Panx2 supports this notion of
a pannexon (Ambrosi et al., 2010), as do cross-linking experi-
ments where SDS-PAGE and Western blots reveal Panx1 bands
at sizes expected for dimeric and hexameric interactions (Boassa
et al., 2007). Intriguingly, similar cross-linking experiments for
Panx2 suggest that they may actually form octameric structures,
which is a arrangement that Cxs have not been reported to assume
(Ambrosi et al., 2010). Cross-linking experiments have not been
performed using Panx3, which has an approximate monomeric
weight of 42 kDa, but a Panx3 band with a mass of about 70 kDa
has been observed in standardWestern blot experiments (Penuela
et al., 2007). This larger band was initially thought to represent a
dimer resistant to dissociation during SDS-PAGE (Penuela et al.,
2007; Celetti et al., 2010; Turmel et al., 2011), but further efforts
to disrupt it with stronger reducing agents have been unsuccess-
ful; the most recent hypothesis is the existence of an alternative
Panx3 splice variant (Cowan et al., 2012). We too have observed
a strong 70 kDa Western blot band in lysates taken from cultured
cells, but we have also identified a similarly sized band in fetal
bovine serum (FBS) (Bond, 2012). It is currently unclear whether
the FBS band represents the same glycoprotein that Cowan et al.
(2012) visualized using three different antibodies, but investiga-
tors should be cognizant of FBS as a source of experimental error
when interpreting their results.
Immunoprecipitation experiments have suggested that het-
eromeric pannexons can also form, composed of Panx1 and
Panx2 or Panx1 and Panx3, but not between Panx2 and Panx3
(Bruzzone et al., 2005; Penuela et al., 2009). However, heteromeric
intermixing does not appear to be conducive to channel activity,
with Panx1/2 co-expression reducing the size of voltage-activated
currents relative to Panx1 expression alone (Bruzzone et al.,
2005). The configuration is also not overly stable, as Panx1/2
pannexons degrade much more rapidly than their monomeric
counterparts (Ambrosi et al., 2010).
Posttranslational modification
Phosphorylation is such a crucial regulator of Cx function and
life cycle (Solan and Lampe, 2009; Chen et al., 2012) that it was
surprising when phosphatase treatment failed to cause a mobility
shift of Panx during SDS-PAGE (Boassa et al., 2007; Penuela et al.,
2007). More recently, however, indirect evidence for Src family
kinase phosphorylation of tyrosine 308 of Panx1 has emerged,
quite possibly as a means of opening the channel (Weilinger
et al., 2012). Furthermore, broad specificity anti-phospho anti-
bodies suggest that the threonine residue at position 387 and one
or more of the serine residues at positions 159, 206, 328, 343,
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394, and 405 of Panx1 can be phosphorylated (Riquelme et al.,
2013). As was reported for tyrosine 308 phosphorylation, ser-
ine/threonine phosphorylation is also correlated with increased
membrane permeability.
The addition of S-nitrosothiol groups onto cysteine residues
is a broadly utilized form of reversible protein modification, and
both Panx1 and Panx3 are receptive to exogenous application
of nitric oxide (NO) donor molecules (Lohman et al., 2012b;
Penuela et al., 2014). S-nitrosylation of Panx1 residues 40 (first
transmembrane domain) and 346 (C-terminal tail) closes the
channel (Lohman et al., 2012b), providing a tantalizing model for
the regulation of Panx1 activity in the circulatory system where
NO is an important paracrine factor. It is still unclear, however,
whether this is an important mechanism in vivo. Panx2 is not
susceptible to S-nitrosylation (Penuela et al., 2014), but it may
be a target for palmitoylation on residue 246, where it has been
suggested to regulate membrane targeting (Swayne et al., 2010).
While thorough analyses into how phosphorylation, nitrosy-
lation, and palmitoylation affect Panx dynamics are only just
beginning, glycosylation is a well-described feature. Sugar moi-
eties are first attached in the endoplasmic reticulum (ER) to
residue N254 of Panx1 (N246 on both fish ohnologs, plus N71
and N95 on Panx1b), N86 of Panx2, and N71 of Panx3 to cre-
ate high mannose chains (Dvoriantchikova et al., 2006a; Boassa
et al., 2007; Penuela et al., 2007, 2009; Prochnow et al., 2009b;
Kurtenbach et al., 2013). Panx1 and Panx3 then move into the
Golgi for further processing of their high mannose groups into
a mature “complex” form before they move on to the plasma
membrane, while the sugars attached to Panx2 appear to stay
as high mannose (Penuela et al., 2009; Bhalla-Gehi et al., 2010).
Blocking N-glycosylation through site directed mutagenesis or by
pharmacological agents reduces the ability of Panxs to traffic to
the plasma membrane (Boassa et al., 2007; Penuela et al., 2007;
Kurtenbach et al., 2013). Neither sialylation nor O-glycosylation
appear to be a feature of any Panx isotype (Penuela et al., 2014).
Interacting proteins
Co-immunoprecipitation has been the predominant method
used to identify the growing list of Panx-interacting proteins.
As will be discussed in greater detail in section Gating, there
is a well-established functional relationship between Panx1 and
the ATP-gated ion channels known as P2X receptors, but there
is also a physical relationship. Of the seven P2X receptor sub-
types, P2X2R, P2X3R, P2X4R, and P2X7R have been shown
to co-immunoprecipitate with Panx1 (Pelegrin and Surprenant,
2006; Silverman et al., 2009; Li et al., 2011b; Poornima et al.,
2012; Hung et al., 2013; Kanjanamekanant et al., 2013), and
in the case of P2X7R, proline 451 within an SH3 domain of
the C-terminal tail of the receptor is involved in the inter-
action (Iglesias et al., 2008; Sorge et al., 2012). P2X7R helps
regulate innate immunity through an association with a multi-
protein complex known as the inflammasome, and Panx1 also
co-immunoprecipitates with many inflammasome components,
including NLRP1, NLRP2, NLRP3, ASC, caspase-1, caspase-11,
and XIAP (de Rivero Vaccari et al., 2009; Silverman et al., 2009;
Minkiewicz et al., 2013; Wang et al., 2013a). It still remains to
be determined whether these proteins bind directly to Panx1 or
if the associations are adaptor-mediated. G protein-coupled P2Y
receptors are a second major class of ATP binding proteins that
are thought to associate with Panx1, probably as part of a complex
(Buvinic et al., 2009).
The C-tail of Panx1 co-immunoprecipitates with actin and the
actin interacting protein Arp3 (Bhalla-Gehi et al., 2010; Wicki-
Stordeur and Swayne, 2013), and pharmacological disruption of
the microfilaments (but not of tubulin microtubules) reduces cell
surface stability and motility of both Panx1 and Panx3 (Bhalla-
Gehi et al., 2010). In line with a direct interaction between the
actin cytoskeleton and Panx, there is significant localization of
zebrafish Panx1 to active areas of the cell membrane where actin
is highly dynamic, such as ruffles (Bond et al., 2012).
Other proteins that have been shown to associate with Panxs
include Kvβ3, which regulates the gating effects of redox potential
on Panx1 (Bunse et al., 2005, 2009); the α1-adrenergic receptor,
possibly as part of a signaling microdomain that controls vascular
smooth muscle tone (Billaud et al., 2011); a voltage-gated L-type
calcium channel, Cav1.1 (also known as the dihydropyridine
receptor), which is found in the transverse tubules (T-tubules)
of skeletal muscle and might play a role in mediating an inter-
action between Panx1 and P2Y2 (Buvinic et al., 2009; Jorquera
et al., 2013; Valladares et al., 2013); SAP97, which facilitates pro-
tein complex formation and trafficking to the plasma membrane
via an association between an SH3-Hook-guanylate kinase (GUK)
domain and the C-terminal tail of Panx1 (Dolmatova et al., 2012);
and stomatin, which inhibits Panx1 channel activity when bound
to the C-terminus (Zhan et al., 2012).
THE PANNEXIN CHANNEL
Given their relationship to the Inxs, it was initially thought that
Panxs were gap junction-forming proteins. Today, that notion has
mostly been repudiated, and Panxs are now understood to form
large gated pores between the intracellular and extracellular space,
in a way that is reminiscent of Cx hemichannels.
Intercellular gap junctions
A small body of work indicates that, under certain circumstances,
Panx-based intercellular channels will form. For example, over-
expression in Xenopus paired oocytes reveals appreciable levels
of transjunctional current attributable to Panx1 or co-expressed
Panx1/2 (Bruzzone et al., 2003). However, it takes a very long
time for these channels to accumulate (upwards of 24 h), and
the macroscopic currents are weak compared to Cx-based gap
junctions (Boassa et al., 2007). For gap junctions, these chan-
nels are uncharacteristically insensitive to transjunctional voltage,
with recorded currents varying linearly with membrane potential
even at large driving forces (>+60mV or<−60mV) (Bruzzone
et al., 2003); with Cx-based gap junctions, differences in electrical
potential between coupled cells inactivates the channel (González
et al., 2007).
Intriguingly, enzymatic removal of bulky N-glycans from the
cell surface dramatically enhances the ability of Panx1 pannex-
ons to couple (Boassa et al., 2008), implying that even though the
Panxsmay retain an ancestral ability to form patent gap junctions,
this configuration is largely inhibited in vivo through steric inter-
ference. Nonetheless, Panx gap junctions have still been inferred
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following over-expression in cultured cell lines. Rat C6 glioma
cells appear to acquire the ability (albeit a weak one) to pass sul-
forhodamine 101 when Panx1 is introduced (Lai et al., 2007), and
the human prostate adenocarcinoma line LNCaP shows increased
movement of calcium between neighboring cells following Panx1
transfection (Vanden Abeele et al., 2006). Panx2 has not been
reported to form gap junctions, and the only evidence for Panx3-
based intercellular channels is dependent on measurements of
calcium wave propagation between cultured osteoblast (Ishikawa
et al., 2011).
Concerns and rebuttals have been published in response to
all of the studies supporting Panx-based coupling, such as the
potential for a non-physiologically relevant response to mas-
sive over-expression, a lack of proper control for induction of
endogenous Cxs, and a general inability within the community to
observe Panx behaving in a fashion expected from a gap junction,
such as sequestration to areas of cell-to-cell contact (Dahl and
Harris, 2009; Ambrosi et al., 2010; Sosinsky et al., 2011; Penuela
et al., 2012). In reality, the general attitude toward Panx gap junc-
tions has largely degraded from “common cellular feature” to that
of “academic peculiarity.” The hypothesis that the primary func-
tion of Panx is to form non-junctional channels was first formally
outlined in 2006 (Dahl and Locovei, 2006), and while a complete
disavowal of physiologically relevant Panx gap junctions may not
necessarily be prudent, the burden of proof currently rests heavy
on the shoulders of anyone making such a claim.
Non-junctional channels
Since the very first biophysical study performed by Roberto
Bruzzone in 2003, Panx1 has been known to form non-junctional
channels that mediate robust macroscopic currents across the
plasma membrane of individual cells (Bruzzone et al., 2003).
These channels have often been characterized by a unitary con-
ductance ranging from ∼300 pS to >500 pS, depending on the
charge carrier (Bao et al., 2004; Locovei et al., 2006a; Prochnow
et al., 2009a,b; Iglesias et al., 2010; Kurtenbach et al., 2013), with
non-selective permeability to solutes smaller than 1.0–1.5 kDa
(Wang et al., 2007). The channel tends to open at positive mem-
brane potentials and requires 30–70ms to transition from fully
closed to fully open (Bruzzone et al., 2003; Bao et al., 2004; Ma
et al., 2009; Prochnow et al., 2009b). There are also at least five
open substates (corresponding to 5, 25, 30, and 90% of the fully
open unitary conductance) (Bao et al., 2004) and, following acti-
vation, Panx1 channels will often deactivate again over several
seconds to a lower subconductance state (Bruzzone et al., 2003;
Bao et al., 2004). It is becoming clear, however, that the cel-
lular context in which Panx finds itself has influence over the
channel’s biophysical properties, as recent unitary recordings of
Panx1 channels excised from over-expressing HEK293 cells reveal
an upper conductance limit of 60–70 pS (Romanov et al., 2011,
2012; Ma et al., 2012) and size exclusion of molecules as small
as 237 Da (Romanov et al., 2012). While studying the zebrafish
Panx1b-EGFP channel, over-expressed in HeLa cells, we too have
observed a much smaller unitary conductance (123 pS) from
excised membrane patches (Bond et al., 2012). Cell type must be
carefully chosen when designing future experiments, and investi-
gators should be especially mindful of the conditions used during
recordings if attempting to compare between their own results
and those reported in other studies. To help the field reach con-
sensus, a standardized patch clamp paradigm for eliciting Panx1
currents has been proposed by Grundken and colleagues, so
if practical, investigators may want to consider adopting their
method (Grundken et al., 2011).
The initial oocyte studies, which revealed such robust Panx1
channel activity in response to membrane potential, completely
failed to note currents attributable to either Panx2 or Panx3
(Bruzzone et al., 2003). Subsequent work using sulforhodamine
B uptake as a readout suggests that both of these proteins can
indeed form cell surface channels that are activated by mechani-
cal stimulation (i.e., from the fluid shear force caused by dripping
dye directly onto monolayer cell culture) (Penuela et al., 2007,
2009; Celetti et al., 2010). Other work has taken the analysis of
Panx2 a step further by showing how purified baculovirus lipo-
somes become permeable to ascorbate if Panx2 is present, and
how electrophysiological measurements are possible in oocytes if
a protracted voltage ramp protocol (−100 to +100mV over 70 s)
is implemented (Ambrosi et al., 2010). Heteromeric Panx1/2 pan-
nexons also show channel activity, but the resultant currents are
significantly lower than those from homomeric Panx1 channels,
and no channel activity has been reported for Panx1/3 or Panx2/3
heteromers (Bruzzone et al., 2003).
Pharmacological blockers
To help tease apart the details of Panx function, efficacious and
highly selective drugs that block channel activity are desirable.
Several compounds have been identified that suppress Panx1 cur-
rents, with varying potency and specificity, and some have been
used to great effect in the collective effort to understand the
physiological relevance of this channel. Carbenoxolone (CBX) is
a synthetic derivative of glycyrrhetinic acid (found in licorice)
that has been used to reversibly block Cx-based channels for
over 25 years (Davidson et al., 1986). CBX was also one of the
first agents shown to directly inhibit Panx1 currents (Bruzzone
et al., 2005), although Panx channels are much more sensitive
to the drug than are Cx channels (Bruzzone et al., 2005), so
low-dose CBX (10–30μM) is commonly used to differentiate
between Panx activity and Cx hemichannels (Huang et al., 2007;
Ma et al., 2009; Li et al., 2012a; Zhang et al., 2012b). Mefloquine
is another compound that reversibly blocks both Panx and Cx
channels at different concentrations; Panx1 channels are inhib-
ited with an IC50 of ∼50 nM (Iglesias et al., 2010), as compared
to >10μM for many Cx isotypes (Cruikshank et al., 2004).
A note of caution when using mefloquine, however: there are
marked differences in the efficacy of the two common diastere-
omers, and certain commercial sources may be much less potent
than others (Iglesias et al., 2010). The drug probenecid (clini-
cally used to treat the symptoms of gout) has proven popular
(Dando and Roper, 2009; Lamkanfi et al., 2009; Ransford et al.,
2009; Billaud et al., 2011; Xia et al., 2012) after it was shown to
block Panx1 channels with an IC50 of ∼150μM without affect-
ing Cx channels, even at doses as high as 5mM (Silverman
et al., 2008). Interestingly, the effects of probenecid and CBX
on Panx1 are severely mitigated if the potassium channel sub-
unit Kvbeta3 is present, so in studies where these blockers fail
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to have an effect, the expression of Kvbeta3 should be assessed
before ruling out Panx1 activity (Bunse et al., 2009). The chloride
channel blocker 5-nitro-2-(3-phenylpropylamino)benzoic acid
(NPPB) blocks Panx1 activity with an IC50 of ∼50μM but,
unfortunately, it also acts on Cx hemichannels at a similar con-
centration (Silverman et al., 2008). Another popular reagent is
a mimetic peptide against the first extracellular loop of Panx1,
called 10Panx1, which impedes passage of small ion currents,
dyes, and ATP (Pelegrin and Surprenant, 2006, 2007; Wang
et al., 2007; Reyes et al., 2009; Montalbetti et al., 2011). This
effect can be partially replicated by other peptides of equivalent
size, or by polyethylene glycol with a molecular weight of 1500
Da, so the effect may be caused by molecules of a certain size
becoming lodged within the pore itself rather than from spe-
cific interactions with the extracellular loop (Dahl, 2007; Wang
et al., 2007). Two compounds that show more recent promise are
the anti-diabetic drug glyburide and the food additive Brilliant
Blue FCF (BB FCF). Glyburide was originally developed to block
ATP-regulated potassium channels, but it will also inhibit Panx1
activity with an IC50 of 45μM (Qiu et al., 2011). Glyburide’s
effect on Cx channels has not been reported. BB FCF inhibits
Panx1 at an IC50 of 270 nM, with no measurable effect on Cx46
or Cx32E143 hemichannels at concentrations as high as 100μM
(Wang et al., 2013b).
As with all pharmacologically based experimentation, off-
target effects must be considered when drawing conclusions from
observations in the presence of Panx inhibitors. More stark atten-
tion has been drawn to this caveat with the recent availability
of Panx knockout mice; for example, dramatic effects on the
progression of chlamydia infection are seen in the presence of
probenecid, CBX, and glyburide, yet infection and sensitivity to
these compounds are the same for both wild-type and Panx1−/−
cells (McKuen et al., 2013). This is not an isolated case either,
and more examples will be discussed in subsequent sections. All
authors are strongly encouraged to implement as much redun-
dancy as logistically possible when designing experiments that
target Panx activity, using aminimumof two blocking agents with
different modes of action, and preferably including a knock-down
or knockout approach. For a more thorough discussion of Panx1
inhibitors, please refer to Dahl et al. (2013).
Gating
Panx1 channels are generally gated shut to prevent degradation of
the electrochemical gradient across the plasma membrane. The
channels are sensitive to voltage, and have very low open prob-
ability at the normal (i.e., negative) resting potential (Bruzzone
et al., 2003). At positive voltages, the characteristic high conduc-
tance pore does become evident, but aside from excitable cell
types like neurons and myocytes, membrane potentials above
0mV are uncommon. Panx1 channel activity is also suppressed by
acidification of the cytoplasm (Locovei et al., 2006b; Kurtenbach
et al., 2013), increased intracellular redox potential (Bunse et al.,
2009, 2010, 2011), S-nitrosylation (Lohman et al., 2012b), arachi-
donic acid (Samuels et al., 2013), and (at least partially) through
an interaction with an erythrocyte integral membrane protein
called stomatin (Zhan et al., 2012). To date, four distinct channel
activation mechanisms have been identified:
1) Mechanical stimulation, like increased fluid shear force
(Penuela et al., 2007, 2009; Celetti et al., 2010; Forsyth et al.,
2011), the application of suction to a patch of excised mem-
brane (Bao et al., 2004), or the physical stretching of entire
cells (Xia et al., 2012) increases permeability for the dura-
tion of the stimulus. Cell swelling has also been proposed
as a semi-mechanical stimulus for Panx1 activation (Locovei
et al., 2006a; Li et al., 2010, 2011a,b, 2012a; Islam et al., 2012;
Wicki-Stordeur and Swayne, 2012; Xia et al., 2012), although
compelling arguments have been made that other channels
are often at least partly responsible for solute release follow-
ing hypotonic stress (Liu et al., 2008; Reyes et al., 2009; Islam
et al., 2012).
2) Increasing extracellular potassium concentration ([K+]o) to
≥10mM causes Panx1 channels to open even at hyperpolar-
ized potentials as low as −100mV (Silverman et al., 2009;
Santiago et al., 2011; Suadicani et al., 2012). Enhanced Panx1
activity has also been observed at very high [K+]o, in the
100mM range, but the resultant membrane depolarization in
these experiments would also have a strong activating effect
(Bao et al., 2004).
3) Proteolytic cleavage of the Panx1 C-terminal tail by caspase
3 or caspase 7 at residues 376–379 results in a constitu-
tively open channel, generally in association with apoptosis
(Chekeni et al., 2010; Qu et al., 2011). Non-covalent bind-
ing appears to occur between the C-tail and the pore interior,
which dissociates once the C-tail has been cleaved (Sandilos
et al., 2012). Interestingly, adding an exogenous peptide into
the cell with the same sequence as the cleaved C-tail fragment
is sufficient to block the processed channel, but only at nega-
tive membrane potentials. The peptide has no effect at positive
potentials, so the cleaved channel behaves “normally” as long
as the peptide is present in a high enough quantity to match
its dissociation constant, thus implying that the extreme C-tail
is involved in the overall voltage sensitivity of the Panx1 chan-
nel (Sandilos et al., 2012). Panx2 is also a substrate for caspase
3 and caspase 7, with cleavage occurring somewhere between
residues 373 and 479 on the C-terminal tail (Penuela et al.,
2014). Penuela et al. also report that Panx3 is not targeted by
caspase, and the consequences of Panx2 cleavage remain to be
explored.
4) Unlike the Cxs, Panxs are insensitive to extracellular cal-
cium ([Ca2+]o) (Bruzzone et al., 2005; Ma et al., 2009).
On the other-hand, rises in intracellular calcium ([Ca2+]i)
to mM levels allow Panx1 channels to open readily at nor-
mal resting potentials (Locovei et al., 2006b; Prochnow et al.,
2009b; Orellana et al., 2013a). Several physiological pro-
cesses known to generate this level of [Ca2+]i have been
suggested or shown to influence Panx1 activity, including caf-
feine stimulation of the ryanodine receptor (Kienitz et al.,
2011), thrombin activation of protease-activated receptor-1
or histamine activation of the histamine receptor (Godecke
et al., 2012; Pinheiro et al., 2013b), adrenergic receptor alpha1
and muscarinic acetylcholine receptor activation of q-subtype
G-protein (Sumi et al., 2010) and, perhaps most importantly,
stimulation of various purinergic receptors (Locovei et al.,
2006b; Pelegrin and Surprenant, 2006). Members from the
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P2Y and P2X receptor classes have both been implicated in
ATP-mediated Panx1 activation, but each does so via different
mechanisms. P2Y1R and P2Y2R are G protein-coupled recep-
tors that mediate calcium release from internal stores through
phospholipase C-dependent inositol 1,4,5-triphosphate (IP3)
generation (Kügelgen, 2006), and both induce Panx1 currents
following ATP stimulation (Locovei et al., 2006b; Zhang et al.,
2012b). On the other hand, the P2XRs are themselves channel
proteins and, upon activation, can increase [Ca2+]i by facil-
itating transit across the plasma membrane from the extra-
cellular space. Direct interaction between P2XRs and Panx1
(Li et al., 2011b) could ensure that local increases in [Ca2+]i
are detected by Panx channels; this would result in a bipha-
sic current as ions first flow through open P2XRs, followed
by a larger current as Panx1 channels open in response. ATP-
dependent biphasic currents have in fact been measured, and
they have also shown sensitivity to pharmacological inhibition
and knockdown of Panx1 (Pelegrin and Surprenant, 2006;
Iglesias et al., 2008), but extreme care must be taken. Large
secondary pores have still been observed following ATP treat-
ment when Panx1 is knocked-down or knocked-out, possibly
due to P2X7R dilation or through an interaction with another
as yet unidentified channel (Hanley et al., 2012; Rigato et al.,
2012; Xu et al., 2012; Alberto et al., 2013). Furthermore, the
P2X7R antagonists brilliant blue-G and KN-62 have both been
reported to increase Panx1 channel function under normoxic
and ischemic conditions in cultured rat astrocytes, suggesting
that P2X7R might be inhibitory toward Panx1 under certain
conditions (Iwabuchi and Kawahara, 2011). Unfortunately,
the results of Iwabuchi and Kawahara are somewhat diffi-
cult to interpret, because the rat P2X7R ortholog is known to
be completely insensitive to KN-62 (Donnelly-Roberts et al.,
2009), and multiple independent sources have come to the
opposite conclusions when employing these drugs (Iglesias
et al., 2008; Qiu and Dahl, 2009; Lemaire et al., 2011).
A consequence of Panx1 activation by P2 receptors is the poten-
tial for positive feedback. With a pore permeable to solutes up
to 1.5 kDa (Wang et al., 2007), Panx1 channels are expected
to allow ATP (0.5 kDa) to flow along its concentration gradi-
ent from the cytosol to the extracellular space, where more cell
surface purinergic receptors await activation. Indeed, the perme-
ability of Panx1 channels to ATP was first demonstrated with
a set of clever reversal potential measurements, using a patch
pipette with an ATP gradient between the pipette and bath solu-
tion (Bao et al., 2004); subsequent work with Panx blocking
drugs and siRNA add additional support (Xiao et al., 2012).
Positive feedback does not lead to constitutively open channels,
however, because ATP binds to the first extracellular loop of
Panx1 at residue R75 and forces the channel into a lower, ATP
impermeable, sub-conductance state (Qiu and Dahl, 2009). The
concentration of ATP needed to stimulate P2X7R is 50–100 fold
lower than is required to deactivate Panx1 (Qiu et al., 2012),
so the system provides an elegant mechanism for amplifying
an ATP stimulus while still maintaining control. UTP and GTP
will also bind to Panx1 (Ma et al., 2009), but are probably not
physiologically relevant because they are unlikely to ever reach
sufficient extracellular concentrations to become inhibitory. As
should be expected, ATP is not exclusively autocrine in nature,
and if Panx1 channels are activated in a single cell, the released
nucleotides will diffuse outward to stimulate other receptive cells
nearby (Iglesias and Spray, 2012). Some controversy has recently
arisen with regard to the “ATP-induced ATP release” mechanism,
because Panx1/2 double knockout astrocyte cultures still increase
extracellular ATP in a CBX-sensitive response to P2X7R activa-
tion (Bargiotas et al., 2011). Other ATP release mechanisms are
known to be independent of Panx1 (Lemaire et al., 2011; Qiu
et al., 2011; Islam et al., 2012), so investigators are encouraged to
always exercise caution when interpreting changes in extracellular
ATP levels.
EXPRESSION AND DISTRIBUTION
Northern blotting was used to generate the first Panx expression
profile, using commercially available mRNA samples frommouse
(Bruzzone et al., 2003) and human (Baranova et al., 2004). This
initial work revealed that Panx1 is expressed in a wide variety of
tissues (an observation more recently supported with qPCR by
Hanstein et al., 2013), Panx2 is largely restricted to the central ner-
vous system, and there is very little Panx3 expression in any adult
tissue with the possible exception of skin. Notable discrepancies
existed between these two studies, however, such as very high
levels of Panx1 in the heart, skeletal muscle, and testis from the
human samples vs. nearly undetectable levels in the mouse, and
there was surprisingly weak Panx2 expression in human spinal
cord compared to extremely high levels in the mouse. As will be
discussed in the following sections, the tissue distribution of Panx
mRNA has been reassessed since these preliminary surveys, along
with a great number of other details as antibodies have become
available. Furthermore, evidence will be reviewed that reveals how
Panx expression within tissues is often cell type-specific and, in
many cases, developmentally regulated.
Trafficking
As integral membrane proteins, Panxs are synthesized at the ER
(Vanden Abeele et al., 2006; Boassa et al., 2008; Bhalla-Gehi et al.,
2010; Iwamoto et al., 2010). Exogenous over-expression experi-
ments suggest that Panx1 and Panx3 can be retained in the ER
as functional calcium leak channels (Vanden Abeele et al., 2006;
Ishikawa et al., 2011), and depending on the cell type, the frac-
tion of Panx retained inside the cell can be significant (Penuela
et al., 2008). In cell types where targeting to the plasma mem-
brane is evident, however, Panx traffics first to the Golgi via
Sar1-dependent COPII vesicles (Bhalla-Gehi et al., 2010) and,
in the case of Panx1 at least, glycosylation plays a critical role
in regulating this movement (Boassa et al., 2007; Penuela et al.,
2007). While in the ER, Panx1 is initially N-glycosylated to a
high mannose form (GLY1) that can be separated from the
un-glycosylated form (GLY0) using SDS-PAGE; the high man-
nose polysaccharides are then further processed into a complex
form (GLY2) in the Golgi (Boassa et al., 2008). Translocation
of Panx to the plasma membrane is severely disrupted in the
presence of glycosylation inhibiting drugs or if the extracellu-
lar asparagines are mutated (Boassa et al., 2007; Penuela et al.,
2007, 2008, 2009; Kurtenbach et al., 2013). Once at the cell
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surface, Panx1 is sequestered in Triton X-100 insoluble lipid
rafts (Dvoriantchikova et al., 2006b), and can remain there for
hours or days (Penuela et al., 2007; Boassa et al., 2008). When
removed from the membrane, they appear to be shuttled off
to lysosomes for degradation (Boassa et al., 2007; Gehi et al.,
2011). Internalization does not seem to be mediated by any of
the standard clathrin, caveolin, or dynamin-dependent endocytic
pathways, so it remains unclear how turnover is coordinated
(Gehi et al., 2011). Panx2 is an enigma, because it often localizes
to small intracellular vesicles (Zappalà et al., 2007; Lai et al., 2009;
Bond et al., 2012). Co-localization of Panx2 and the mannose-6-
phosphate receptor suggests that the endolysosomemay be at least
one intracellular target (Wicki-Stordeur et al., 2013), although
no overlap was observed between exogenous GFP tagged Panx2
and LysoTracker® or EEA1 in C6 glioma cells (Lai et al., 2009).
Panx2 does, nevertheless, traffic to the plasma membrane under
certain circumstances (Ambrosi et al., 2010), perhaps in response
to de-palmitoylation (Swayne et al., 2010).
Bone
Osteogenic cell types are of particular interest because they are
among the very few to express Panx3. Cultured osteoblasts up-
regulate Panx3 when stimulated to differentiate and mineralize
(Penuela et al., 2007, 2008; Bond et al., 2011; Ishikawa et al.,
2011), as do the ATDC5 and N1511 chondrocytic cell lines
(Iwamoto et al., 2010). At the tissue level, immunohistochem-
istry reveals strong Panx3 expression in bones derived from both
endochondral ossification (EO) as well as intramembranous ossi-
fication (IO) (Wang et al., 2009; Iwamoto et al., 2010; Bond
et al., 2011; Ishikawa et al., 2011), and closer examination of EO-
derived long bones reveals that growth plate chondrocytes begin
to express Panx3 during the pre-hypertrophic to hypertrophic
stage of differentiation (Iwamoto et al., 2010; Bond et al., 2011).
The transcription factor Runx2 is a key regulator of the Panx3
gene during osteogenesis (Bond et al., 2011), and over-/under-
expression studies have shown how cultured osteoblasts and
chondrocytes require Panx3 for normal differentiation (Iwamoto
et al., 2010; Ishikawa et al., 2011). Panx1 has also been detected
in osteoblasts, although its purpose in these cells has not been
explored (Penuela et al., 2008).
Bladder
While Panx1 is distributed widely throughout the body, it appears
to be particularly enriched in the urinary bladder (Hanstein et al.,
2013). Immunohistochemistry reveals substantial expression in
the 3–5 layers of urothelial cells closest to the bladder lumen, with
little to no expression in the immediately underlying suburothe-
lial layer (Timóteo et al., 2013). Unfortunately, Timóteo et al. did
not include the detrusor muscles (responsible for bladder con-
traction) in their published results, but qPCR indicates that Panx1
can also be found there (Negoro et al., 2013).
Brain
RT-PCR amplification has detected mRNA expression of all
three rat Panxs in primary astrocytes and whole brain extracts
(Lai et al., 2007; Wang et al., 2009). In rodents, relative Panx1
expression within the whole brain peaks in late embryonic/early
neonatal animals, and is dramatically reduced in adults (Vogt
et al., 2005; Ray et al., 2005). This pattern may arise because
neuroblast cells, which are abundant early in brain develop-
ment, express high levels of Panx1 (Wicki-Stordeur et al., 2012);
down-regulation then occurs as these stem cells differentiate into
mature neurons and glia. This is not to say that expression is uni-
formly turned off, as many neural subtypes continue to express
appreciable levels of Panx1; these mature neurons include exci-
tatory principal cells, cortical and hippocampal interneurons,
GABAergic Purkinje cells, dopaminergic neurons, and choliner-
gic motoneurons (Ray et al., 2005; Zappalà et al., 2006; Zoidl
et al., 2007). In situ hybridization and immunofluorescence illus-
trate this clearly, by most intensely labeling neuron rich regions
like the hippocampus (especially the dentate gyrus), cerebellum,
inferior olive, substantia nigra, thalamus, layer V of the pre-
frontal cortex, and the glomular, mitral cell, and granule cell
layers of the olfactory bulb (Weickert et al., 2005; Zappalà et al.,
2006; Zoidl et al., 2007; Zhang et al., 2012a; Cone et al., 2013).
Pools of undifferentiated Panx1-positive neural progenitor cells
also remain in the postnatal brain, such as those found in the
ependymal/sub-ependymal layer of the lateral ventricles (Wicki-
Stordeur et al., 2012; Wicki-Stordeur and Swayne, 2013). At the
subcellular level, Panx1 is often observed localizing to neuronal
synapses on the postsynaptic side of the cleft (Zoidl et al., 2007),
although the soma of certain neurons (particularly in the thala-
mus) will also sequester Panx1 (Cone et al., 2013). Functionally,
it has been proposed that the pool of postsynaptic Panx1 has
a role to play in long-term potentiation and synaptic plasticity
(Prochnow et al., 2012). While most of the Panx1 expressing cells
identified in the brain are positive for NeuN (a neuron specific
marker), co-expression with the glial marker GFAP has also been
observed in tissue sections (Zappalà et al., 2006; Santiago et al.,
2011) and primary astrocyte cultures (Huang et al., 2007; Lai
et al., 2007; Locovei et al., 2007; Liu et al., 2008; Iglesias et al.,
2009). Cerebellar white matter oligodendrocytes are also a possi-
ble source of Panx1 in the brain, but conflicting observations have
been reported (Bruzzone et al., 2003; Ray et al., 2005; Vogt et al.,
2005; Ray et al., 2006; Zappalà et al., 2006). As will be discussed
in more detail below, innate immune system leukocytes express
Panx1, and the phagocytic microglia dispersed throughout the
brain are no exception (Rigato et al., 2012).
In contrast to Panx1, Panx2 expression is much lower early in
brain development, but then becomes more pronounced in the
adult (Vogt et al., 2005). The subcellular distribution of Panx2
also changes considerably as neurons mature. It is predominantly
intracellular in immature neuronal progenitor cells, then follow-
ing a brief period where expression is suppressed as the progenitor
cells transition toward terminal differentiation, mature neurons
shuttle Panx2 all the way to the plasma membrane (Swayne
et al., 2010). Many different neural subtypes throughout the
brain express the protein, with no apparent correlation to specific
neurotransmitter molecules, degree of electrical connectivity, or
cellular origin (Zappalà et al., 2007).
Panx3 has been observed at the transcript level in human
fetal hippocampal mRNA (Baranova et al., 2004), whole rat brain
mRNA (Wang et al., 2009), and cultured rat astrocytes (Lai et al.,
2007), but it has been reported as absent from whole mouse brain
mRNA (Bruzzone et al., 2003; Penuela et al., 2007; Wang et al.,
2009).
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Circulatory system
Panx1 is found throughout the pulmonary and systemic arterial
system, although the relative distribution between the epithe-
lial and smooth muscle layers can be different depending on the
artery. For example, Panx1 is readily observed in both the epithe-
lium and smooth muscle of smaller arteries and arterioles, while
it is restricted to the endothelium of the aorta and femoral artery
(Billaud et al., 2011; Lohman et al., 2012a), and the smooth mus-
cle cells of the middle cerebral artery (Burns et al., 2012). Panx2
can be found in both endothelial and smooth muscle cells of the
middle cerebral artery (Burns et al., 2012), and Panx3 has been
reported in small arteries less than 100μm in diameter, particu-
larly in the kidney (Lohman et al., 2012a). Panx1 expression has
also been reported in human erythrocytes (Locovei et al., 2006a),
although a more recent attempt to detect the protein in these cells
with different antibodies was unsuccessful (Melhorn et al., 2013).
Ear
Panx1 is expressed by many of the cells found throughout the spi-
ral limbus, organ of Corti, spiral prominence (along the cochlear
lateral wall), and Reissner’s membrane (Wang et al., 2009). In the
organ of Corti, expression is restricted to the rostral epithelial cells
early in development (E16.5 in mouse); as the animal matures,
expression is induced in both the inner and outer sulcus, Claudius
cells, and neurons in the Scarpa’s and spiral ganglia (Tang et al.,
2008). Panx2 expression has very little overlap with Panx1, except
in the Scarpa’s and spiral ganglia neurons in the organ of Corti
(Tang et al., 2008). There is, however, prominent Panx2 expres-
sion in the stria vasularis side of the boundary between the stria
vasularis and spiral ligament in the cochlear lateral wall (Wang
et al., 2009). Panx3 is restricted to the bones of the cochlear lateral
wall and modiolus (Wang et al., 2009).
Eye
In the mouse retina, Panx1 is expressed in the ganglion cell layer
(along with Panx2), inner nuclear layer, outer plexiform layer, and
at the periphery of the outer nuclear layer (primarily in ganglion,
amacrine, bipolar, and horizontal cells), with very little expres-
sion in the inner plexiform layer. Panx1 levels are highest in the
juvenile retina, although retinal ganglion cells retain expression
into adulthood (Ray et al., 2005; Dvoriantchikova et al., 2006a,b;
Kranz et al., 2013). At the subcellular level, Panx1 can be observed
in the dendrites and axons of horizontal cells and type 3a OFF
biopolar cells (Kranz et al., 2013). The two Panx1 ohnologs in
teleost fish are both represented in the retina with a similar com-
bined expression pattern as mammalian Panx1, although each is
expressed in different cell layers (Panx1a: outer plexiform layer.
Panx1b: inner nuclear and ganglion cell layers) (Prochnow et al.,
2009b; Kurtenbach et al., 2013).
Gastrointestinal
An immunohistochemistry survey for Panx1 in the human colon
(using a polyclonal antibody against a C-terminal peptide) has
revealed expression throughout all major layers, with particularly
high levels in the submucosal and myenteric ganglia (Diezmos
et al., 2013). Gulbransen et al. (2012) have shown that the gan-
glion neurons, as opposed to supporting glial cells, are the source
of this Panx1 expression, and that these neurons are sensitive to
extracellular ATP; they undergo apoptosis following activation
of P2X7R during the early stages of inflammatory bowel dis-
eases (e.g., Crohn’s disease). Based on the protective effects of
probenecid and 10Panx1, it is argued that Panx1 propagates a wave
of damage away from the initial point of injury by further increas-
ing extracellular ATP around affected neurons (Gulbransen et al.,
2012). It will be important to repeat the work of Gulbransen
et al. with Panx1−/− animals, however, because probenecid and
10Panx1 have recently been shown to dampen the inflamma-
tory response independent of their effect on Panx1 (Wang et al.,
2013a).
Immune system
As we will see in section Inflammation and immunity, a
lot of effort has been expended to understand how Panxs
affect the immune response. The presence of Panx1 in
macrophages (including microglia) is well-established (Pelegrin
and Surprenant, 2006; Kanneganti et al., 2007; Pelegrin and
Surprenant, 2007; Marina-Garcia et al., 2008; Pelegrin et al., 2008;
Brough et al., 2009; Lamkanfi et al., 2009; Kronlage et al., 2010;
Bargiotas et al., 2011; Lemaire et al., 2011; Qu et al., 2011; Hanley
et al., 2012; Rigato et al., 2012); its presence has also been reported
in T-cells (Schenk et al., 2008; Woehrle et al., 2010a,b) and poly-
morphonuclear neutrophils (Chen et al., 2010; Bao et al., 2013).
Kidney
Modest expression of Panx1 mRNA and protein has been
observed in kidney using Northern blotting (Baranova et al.,
2004), qPCR (Ray et al., 2005), and Western blotting (Penuela
et al., 2007), while the only support for Panx2 expression comes
from a Northern blot screen (Bruzzone et al., 2003). A more
recent immunofluorescence survey has revealed the cellular dis-
tribution of Panx1 within the nephron, where it can be found
in both cortical and medullary structures, particularly on lumi-
nal surfaces. The loop of Henle, proximal tubules, and collecting
ducts all react to a Panx1 antibody, while the glomerulus and dis-
tal convoluted tubules do not (Hanner et al., 2012). In the renal
blood vessels, Panx1 appears to be restricted to smooth muscle
myocytes, and Panx3 can be found in the juxtaglomerular appa-
ratus and cortical arterioles (Hanner et al., 2012; Lohman et al.,
2012a).
Lung
Panx1 and a small amount of Panx2 are present in primary air-
way epithelial (PAE) cells. When these PAE cells are grown in
an air-liquid interface culture, Panx1 has a striking subcellular
localization to the ciliated apical pole, which is equivalent to the
luminal epithelial surface (Ransford et al., 2009). If bathed in
hypotonic solution (to induce swelling), PAE cells become much
more permeable to propidium iodide and release elevated lev-
els of ATP, and both of these properties are sensitive to Panx
inhibitors and Panx1 siRNA (Ransford et al., 2009). Furthermore,
trachea explant cultures taken from Panx1−/− mice lose nearly all
of their ability to release ATP when exposed to hypotonic solu-
tion (Seminario-Vidal et al., 2011), and Xenopus lung tissue does
not increase ATP release in response to hydrostatic pressure if
pre-treated with probenecid (Richter et al., 2014).
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Reproductive tissue
Both Panx1 and Panx3 are expressed by subsets of cells within
the testis, efferent ducts, and epididymis of the male reproduc-
tive tract (Turmel et al., 2011). Orchidectomy has little effect on
the expression of Panx1 throughout the epididymis, but induces
a dramatic up-regulation of Panx3 unless post-operative testos-
terone is supplied, implying that androgens are able to modulate
Panx3 expression (Turmel et al., 2011).
Skeletal and cardiac muscle
High levels of Panx1 were observed in human skeletal muscle
and heart samples during the initial Northern blot studies per-
formed by Baranova et al. (2004). Further work has since shown
that Panx1 levels are actually relatively low in the heart, and that
the protein exists primarily in the un-glycosylated state (Kienitz
et al., 2011; Dolmatova et al., 2012). That said, Panx1 expression
and glycosylation increases significantly if the heart is subjected
to an ischemic insult (Dolmatova et al., 2012) or if the myocytes
are put into culture (Kienitz et al., 2011). Expression in cul-
tured cardiac myocytes is, however, down-regulated again after
a few days (Kienitz et al., 2011). Large (300 pS) probenecid sensi-
tive ion channels correlate with the Panx1 expression in cultured
cardiac myocytes, and activation of these channels is sufficient
to induce an action potential via voltage-gated sodium chan-
nels (Kienitz et al., 2011). The mouse atrial myocyte cell line
HL-1 does not normally express Panx1, but it does produce
Panx2, and Panx2 siRNA is sufficient to significantly reduce the
stretch-activated release of ATP by these cells (Oishi et al., 2012).
Subjecting HL-1 cells to hypoxia replicates the up-regulation
of Panx1 observed in ischemic heart, and conditioned media
harvested from hypoxic cells is able to stimulate a probenecid
sensitive fibroblast-to-myofibroblast transition; this is reminis-
cent of the fibrosis that occurs in the heart during wound healing
(Dolmatova et al., 2012). In skeletal muscle, Panx1 channels local-
ize to the luminal surface of T-tubules (Jorquera et al., 2013),
where the Panx1-dependent release of ATP is an important medi-
ator of muscle potentiation after repetitive stimuli (Riquelme
et al., 2013). Panx1 may also play an ATP-dependent role in
maintaining [Ca2+]i in muscle fibers after a strong activating
stimulus, possibly through an interaction with the dihydropyri-
dine receptor at the sarcoplasmic reticulum (Buvinic et al., 2009;
Cea et al., 2012). Over-activity of Panx1, however, is thought to
induce myocyte cell death; mutations in the dystrophin gene can
up-regulate Panx1 expression, possibly contributing to the patho-
logical apoptosis that leads to muscle wasting in those suffering
from muscular dystrophy (Valladares et al., 2013). Similarly, den-
ervated muscles experience significant Panx1 up-regulation along
with the onset of atrophy, although the evidence indicates that
Cxs have a much larger impact on cell death than Panx1 (Cea
et al., 2013).
Skin
Immunofluorescence and Western blot studies performed by
Celetti et al. (2010) indicate that Panx1 and Panx3 are both
present in the epidermis. In mouse skin taken from embry-
onic stage 13.5, the outermost layer of cuboidal epithelium,
as well as the underlying mesenchyme, are highly reactive to
Panx1 and Panx3 antibodies. As the mice age, however, epider-
mal Panx1 expression declines, with what remains being found
in the suprabasal cell layer. Forced mis-expression in organotypic
culture results in disorganization of the epidermis and reduced
vital layer thickness (Celetti et al., 2010). Panx3 is not expressed
at appreciable levels in neonatal skin, but diffuse intercellular
labeling can be seen throughout the vital layers of adult tis-
sue (Celetti et al., 2010). The primary pool of epidermal Panx3
is found in the sebocytes associated with hair follicles (Celetti
et al., 2010; Bond et al., 2011). In human, Western blotting exper-
iments confirm Panx1 expression in subcutaneous fibroblasts
(Pinheiro et al., 2013a), and Penuela et al. (2007) have described
human Panx1 as being more punctate in confocal images of
adult facial epidermis than the mouse homolog. On the other
hand, the expression pattern of Panx3 seems to be quite simi-
lar between mouse and human (Penuela et al., 2007). Most of
the epidermis is comprised of keratinocytes, but melanocytes
are also interspersed, and although not explicitly observed in
situ, a melanocyte cell line has been shown to express Panx1
(Penuela et al., 2012).
Tongue
In the large circumvallate papillae (taste buds) found near the
base of the tongue, Panx1 is expressed by chemoreceptor (type
II) cells, as well as by about 50% of presynaptic (type III) cells.
Neither of the other Panx isotypes are present, and only low lev-
els of Panx1 are seen in the surrounding epithelium and muscle
(Huang et al., 2007; Romanov et al., 2007).
PHYSIOLOGICAL AND PATHOLOGICAL RELEVANCE OF PANNEXINS
Pharmacological agents, over-expression techniques, RNAi
knockdown, and mouse knockout lines have all been used to
modulate the activity of Panx channels both in vitro and in vivo,
in an effort to decipher their functional significance. At least
four separate Panx1 knockout mice have now been generated,
and all of them are fertile with no outwardly obvious phenotype
(Anselmi et al., 2008; Bargiotas et al., 2011; Lemaire et al., 2011;
Qu et al., 2011; Santiago et al., 2011; Seminario-Vidal et al., 2011;
Dvoriantchikova et al., 2012; Hanley et al., 2012; Romanov et al.,
2012; Suadicani et al., 2012). A Panx2 knockout mouse has also
been described as viable and healthy (Bargiotas et al., 2011). The
relative innocuousness of Panx knockout has actually caused
some confusion in the community, as it seems to be at odds
with the large body of pharmacological data that has otherwise
implied that Panx activity is quite important for a range of
biological processes. The underlying cause of these discrepan-
cies is still being sorted out, but they could indicate that the
current crop of “specific” Panx inhibitors have off-target effects
awaiting identification, or perhaps compensatory mechanisms
are up-regulated when Panx is removed from the system. To
complicate matters even further, some of the knock-out strategies
are not complete; the methodology employed has created hypo-
morphic tissues instead of completely ablating Panx1 (Hanstein
et al., 2013). Irrespective of these caveats, strongly supported
cases remain that implicate Panxs in physiological and/or
pathological processes, particularly in cells or tissues under
stress.
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Ischemia
The first indication that Panxs might be involved in a spe-
cific pathology was observed in acute brain slices, when Roger
Thompson and colleagues proposed that the massive disruption
in electrochemical gradient which occurs across the plasmamem-
brane of hippocampal neurons challenged with ischemia (i.e.,
oxygen/glucose deprivation, such as occurs during stroke) could
be the result of Panx1 channel activity (Thompson et al., 2006).
The depolarization in question does not occur until after about
10min of continuous ischemic insult, and is reversible if nor-
moxic conditions are reasserted soon after the drop in membrane
resistance develops, but it becomes cytotoxic if allowed to per-
sist for more than ∼5min. Panx1 channel blockers, siRNAs, and
knockout all lessen damage following oxygen/glucose depriva-
tion, thus supporting the hypothesis that Panx1 is indeed involved
(Domercq et al., 2010; Bargiotas et al., 2011; Dvoriantchikova
et al., 2012; Jiang et al., 2012). N-methyl-D-aspartate (NMDA)
receptors could be the upstream cause of these destructive anoxic
depolarization events, by regulating Panx1 permeability via Src
family kinase mediated intracellular signaling (Weilinger et al.,
2012). In addition to the acute neurotoxic properties of Panx dur-
ing ischemia, these channels are also thought to have a negative
impact during the secondary inflammatory response that follows
reperfusion, and this exacerbates damage during the recovery
period (Orellana et al., 2011). As discussed in section Brain, Panx1
and Panx2 are both expressed to varying degrees in neurons and
supporting glia, and knocking out either gene individually in
mice has no significant neuroprotective effects following stroke
(Bargiotas et al., 2011). Knocking out both, on the other hand,
synergistically reduces total infarct size and functional disability,
implying that Panx1 and Panx2 play redundant or compensatory
roles in the CNS (Bargiotas et al., 2011, 2012). Similarly, treat-
ing mice with probenecid before or after middle cerebral artery
occlusion (a common stroke model) reduces infarct volume by
20–30% (Xiong et al., 2014). Another interesting observation dur-
ing this probenecid study of Xiong et al. was a marked reduction
in serum levels of the proinflammatory cytokine HMGB1 in the
treatment group. HMGB1 release has also been linked to Panx1
activity following the phenomenon known as “cortical spread-
ing depression,” which precedesmigraine headache (Karatas et al.,
2013).
In sharp contrast to the detrimental effects Panx expres-
sion seems to have in the nervous system during ischemia,
Panx-dependent release of ATP in the heart has been identi-
fied as a possible component of the cardio-protective phenom-
ena known as ischemic pre-conditioning and post-conditioning.
Using the Langendorf ex vivo perfused model, Donald Vessey
has shown how CBX, mefloquine, and Brilliant Blue G (P2X7R
inhibitor) will all completely block the cardio-protection gained
from ischemic pre-/post-conditioning in a 40min ischemic
insult/40min reperfusion protocol. These blockers have no effect
if exogenous sphingosine 1-phosphate (S1P) or adenosine are
present, indicating that release of S1P and/or adenosine is critical
(Vessey et al., 2010, 2011a). Furthermore, the short ischemic con-
ditioning events can be replaced by treating the heart with ATP
before or after the ischemic insult, but the protective effects of
ATP are lost if Panx or P2X7R inhibitors are present during the
challenge (Vessey et al., 2011b). These effects are likely the result
of Akt/PI3K pathway activation, which is primed during pre-
conditioning for rapid response to subsequent G-protein coupled
receptor activation by S1P (Vessey et al., 2011a,b). Unfortunately,
hearts from Panx1−/− animals have not been used to con-
firm the pharmacological data, so it is still possible that the
cardio-protective release of ATP is attributable to some other
CBX/mefloquine sensitive mechanism.
Seizure
Epileptic-like seizures are caused by dysregulated rhythmic corti-
cal activity. Given that Panx1 can facilitate neuronal depolariza-
tion and over-excitability (as discussed in the previous section),
it stands to reason that it may also exacerbate, or even cause,
these events. To induce epileptic-like seizure in a controlled envi-
ronment, brain slices can be stimulated with NMDA, or live
animals can be treated with the muscarinic acetylcholine 1 recep-
tor agonist pilocarpine or the kainate receptor agonist kainic acid
(Thompson et al., 2008; Kim and Kang, 2011; Santiago et al.,
2011). Intriguingly, interfering with Panx1 activity (using drugs,
RNAi, or knockout) significantly reduces the negative effects of
NMDA and kainic acid induced seizures (Thompson et al., 2008;
Santiago et al., 2011) while worsening the outcome following
pilocarpine treatment (Kim and Kang, 2011). This discrepancy
can perhaps be traced back to the different mechanisms leading to
hyper-excitability following activation of each receptor type: the
muscarinic acetylcholine 1 receptor leads to intracellular accu-
mulation of IP3, and the accompanying rise in [Ca2+]i has a
significant impact on hyper-excitability by depolarizing the cell
(Nash et al., 2004), as well as inducing Panx1 opening (Locovei
et al., 2006b). If IP3 then exits the cell through Panx channels, its
intracellular concentration can once again decline, and normal
[Ca2+]i can be re-established. ATP is released at the same time,
and activation of P2X7R desensitizes the muscarinic acetylcholine
1 receptor (Fukushi, 1999), so Panx1 and P2X7R can ultimately
have a quieting effect if pilocarpine is the agonist used to induce
seizure. Alternatively, Panx1 opening does not provide nega-
tive feedback on the system when NMDA receptors or kainate
receptors are the source of epileptic discharge. Over-activation
of either receptor will induce sustained status epilepticus; this
causes an elevated [K+]o (Fröhlich et al., 2008), which opens
Panx1 channels, thus enhancing excitability by depolarizing the
cell and releasing intracellular ATP stores. While P2X7R activa-
tion may have a quieting effect on the muscarinic acetylcholine
1 receptor, it is believed to potentiate seizure progression when
this receptor is not involved, and depleting intracellular ATP
stores interferes with the phosphorylation state of GABA recep-
tors to decrease the hyperpolarizing effects of these channels
(Whittington et al., 1995). This is a fascinating insight into just
how important context can be when interpreting results relating
to Panx activity—and, indeed, biological processes in general.
While Panx activity influences the progression of seizure
events, the seizures themselves may also influence the expression
of Panx. For example, acute mouse hippocampal slices treated
with Co2+ (another method of evoking seizure events) experience
an ∼1.5-fold increase in Panx1 and Panx2 mRNA, which does
not occur if the actual seizures are suppressed by co-treatment
Frontiers in Physiology | Membrane Physiology and Membrane Biophysics February 2014 | Volume 5 | Article 58 | 12
Bond and Naus The pannexins
with tetrodotoxin (Mylvaganam et al., 2010). Furthermore, ele-
vated Panx1 expression in cortical layer I has been correlated with
human epilepsy, following an analysis of brain tissue collected
during temporal lobe resection (Jiang et al., 2013). Whether this
up-regulation improves or worsens the pathology, however, is yet
to be determined.
Calcium waves
Calcium waves occur when a small subset of cells within a popu-
lation experience a rise in [Ca2+]i, and a signal is then communi-
cated to neighboring cells, which in turn experience their own rise
in [Ca2+]i (Cornell-Bell et al., 1990). This process builds a wave
front that can propagate many dozens of cell lengths from its ori-
gin, and can even spread between cells not in physical contact, so
it is at least partly mediated by an extracellular diffusible agent
(Hassinger et al., 1996). ATP has been identified as the primary
diffusible agent (Guthrie et al., 1999), which binds to G-protein
coupled P2Y receptors on adjacent cells, leading to IP3 synthe-
sis and its associated calcium release from the ER. The elevated
[Ca2+]i ungates Panx1 channels and ATP flows out to propagate
the calcium wave onward (Locovei et al., 2006b). The full story is
more complicated than this model suggests, however, because gap
junctions are also an important mediator of calcium wave pro-
gression when cells are in direct contact (Scemes and Giaume,
2006). Furthermore, when Panx1−/− cochlear organotypic cul-
tures were tested for their susceptibility to calciumwaves, they did
not appear to be hindered (Anselmi et al., 2008). Calcium wave
spread may even be exacerbated by Panx1 knockout, at least in
cultured astrocytes, possibly as a result of increased Cx43 expres-
sion (Suadicani et al., 2012). Given the conflicting reports, further
work is required to clarify whether or not Panxs have a significant
part to play in physiologically relevant calcium wave propagation.
Cancer
Analysis of public gene expression databases reveals a positive
correlation between Panx2 and post-diagnostic survival time in
glioma patients; these analyses also suggest a link (albeit a much
weaker one) between Panx1 and cancer in general (Litvin et al.,
2006). Along these lines, over-expression of Panx1 or Panx2 in
rat C6 glioma cells has been shown to reduce their tumori-
genicity, both in vitro and in vivo (Lai et al., 2007, 2009). The
underlying mechanism for this could reside in a general suppres-
sion of cell cycle progression, which has been shown to occur in
otherwise normal epidermal keratinocytes over-expressing Panx1
(Celetti et al., 2010), or from enhanced actin/actomyosin facil-
itated cellular compaction when Panx1 is present (Bao et al.,
2012); of course, these two processes are not mutually exclusive.
Unlike its effect on glioma, Panx expression in skin cancers may
actually be detrimental. Panx1 and Panx3 expression is lower in
keratinocyte-derived basal cell carcinoma and squamous cell car-
cinoma (Cowan et al., 2012), and a correlation has been reported
between the aggressiveness of three isogenic metastatic melanoma
cell lines and the level of Panx1 expression (Penuela et al., 2012).
Knocking down Panx1 from themost aggressive of themelanoma
lines suppresses certain oncogenic characteristics, and knock-
down also diminishes tumor size and metastases when the cells
are implanted onto the chorioallantoic membrane of a chicken
embryo (Penuela et al., 2012). From a therapeutic standpoint,
Panx1 has been linked to the proinflammatory release of ATP
from tumor cells treated with immunogenic cell death (ICD)
inducing agents like anthracyclines and oxaliplatin (Wang et al.,
2013c; Martins et al., 2014). Unlike the standard model of ATP
diffusion through the Panx1 channel, release from cells undergo-
ing ICD occurs through a vesicular process known as “lysosomal
exocytosis.” Caspase activity, LAMP1, and Panx1 are all necessary
for fusion of ATP filled vesicles with the plasma membrane, but it
is currently unclear why (Martins et al., 2014).
Cell cycle
If Panxs play a role in tumor growth (see previous section), it
is natural to question how these proteins influence cell division.
This is one of the rare cases where Panx3 has received some atten-
tion, and over-expression experiments indicate that this channel
protein is anti-mitotic (Celetti et al., 2010; Iwamoto et al., 2010;
Ishikawa et al., 2011). At the biochemical level, two mechanisms
have been proposed for these observations:
1) Panx3 expression reduces intracellular cyclic-AMP synthe-
sis in response to growth hormone stimulation, leading
to reduced cyclic-AMP-responsive element binding (CREB)
protein associated (i.e., pro-mitotic) transcription (Iwamoto
et al., 2010).
2) Panx3 expression increases [Ca2+]i, possibly as an ER leak
channel, thus increasing calmodulin activity and calcineurin
induced NFATc1 de-phosphorylation, with NFATc1 then pro-
moting differentiation (Ishikawa et al., 2011).
Panx activity is not universally growth suppressive, however,
because over-expressing Panx1 in the neuroblastoma N2a cell line
has been reported to double its proliferation rate (Wicki-Stordeur
et al., 2012). The downstream signaling events controlling Panx1
induced N2a replication have not been directly explored yet, but
extracellular purines are a known mitogen of neural progenitor
cells (Lin et al., 2007).
Cellular morphology and motility
Evidence exists that Panx1 (and, to a lesser extent, Panx2) can
alter cellular morphology. For example, over-expression in cul-
tured C6 glioma cells has a flattening effect that increases the
surface area each cell occupies on the substrate (Lai et al., 2007,
2009). In the case of Panx1, this could be related to interac-
tions between the C-terminal tail of the channel, filamentous
actin, and the actin nucleating protein Arp3 (Bhalla-Gehi et al.,
2010; Wicki-Stordeur and Swayne, 2013). If Panx1 is able to
facilitate nucleation and/or stabilization of actin fibers, then its
presence along the entirety of the plasma membrane would
prevent formation of leading and trailing edges; in essence, uni-
form actin polymerization is analogous to the cell trying to
move in all directions at once, which simply results in cell
spread. Indeed, Panx1 over-expressing C6 cells do tend to have
a more developed actin cytoskeleton (Bao et al., 2012). Other
incoming signals must still be considered though, because highly
motile neuroblast cells express significant levels of Panx1 (Wicki-
Stordeur and Swayne, 2013). Presumably the actin nucleating
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effects of Panx1 at the trailing edge of neuroblast cells are out-
weighed by depolymerization factors, or Panx1 is disproportion-
ately recruited to the leading edge. Panxs have also been observed
to influence the development of neurites in cultured neural
cells; the outgrowth of neurites is enhanced in PC12 cells (Lai,
2010) and hampered in N2a cells (Wicki-Stordeur and Swayne,
2013). In both cases, differentiation of the cultured cells is also
affected by changes in Panx expression, so it remains unclear
whether a direct link exists between neuritogenesis and Panx
channels.
Inflammation and immunity
The induced innate immune response is a crucial line of defense
against microorganisms that breach the skin or mucosal epithe-
lial lining of the airway or gut. In very minor cases, where small
numbers of foreign invaders are present in otherwise healthy
tissue, phagocytes (i.e., macrophages, granulocytes, and den-
dritic cells) will simply engulf and digest the offending cells or
particles. In more severe cases, when the infection is large or
associated with cellular distress, cytokines and chemokines are
released to organize a more aggressive immune response and
inflammation. Two separate activation signals are required within
a few hours to activate induced innate immunity: First, incom-
ing cytokine stimulation (e.g., soluble TNF-α) or exposure to
a foreign microbe-associated molecular pattern (MAMPs, such
as lipopolysaccharides or flagellin) activates the NF-κB pathway,
leading to up-regulated production of the inactive “pro” form
of IL-1β, as well as production of NLRP3 and inflammasome
assembly (Qiao et al., 2012). Pro-IL-1β is stored intracellularly
with a half-life of ∼2.5 h, or until such time as a second stim-
ulus is encountered, which could be an interaction with an
effector T-cell or a “danger signal” like the binding of ATP to
P2X receptors (Solle et al., 2001). Following the second sig-
nal, inflammasome activation ensues; caspase-1 becomes active,
which then processes IL-1β into its bioactive form for release into
the surrounding tissue to stimulate inflammation (for reviews
please see Schroder and Tschopp, 2010; Takeuchi and Akira,
2010).
Pelegrin and Surprenant (2006) were the first to suggest a
connection between Panx1-mediated ATP release and induc-
tion of the innate immune response. They drew a link between
Panx1 and very low resistance pore formation in macrophages
following P2X7R stimulation, and speculated that the channel
was responsible for inflammasome activation and downstream
caspase-1-dependent IL-1β release. A multitude of indepen-
dent studies followed up on this hypothesis by treating stimu-
lated macrophages with Panx-blocking drugs and/or the 10Panx1
mimetic peptide, and both caspase 1 activation and release of
IL-1β are indeed suppressed under these conditions (Kanneganti
et al., 2007; Pelegrin et al., 2008; Marina-Garcia et al., 2008;
Lamkanfi et al., 2009; Wang et al., 2013a). It came as quite a
surprise, then, when stimulated Panx1−/− macrophages suffered
no impairment of large pore formation, inflammasome assem-
bly/activation, or IL-1β processing/release (Bargiotas et al., 2011;
Qu et al., 2011; Turmel et al., 2011; Hanley et al., 2012; Wang
et al., 2013a). The reason for this discrepancy is probably an
off-target effect of the pharmacological agents (as opposed to
a compensatory mechanism induced by loss of Panx1) because
the 10Panx1 peptide continued to suppress inflammasome acti-
vation in Panx1−/− leukocytes (Wang et al., 2013a). Despite
the confusion surrounding inflammasome activation, interfer-
ing with macrophage Panx1 does cause deficiencies in other
respects. For example, probenecid, 10Panx1, and Panx1 siRNA
all restrict ATP release and NO production in microglia fol-
lowing LPS stimulation (Orellana et al., 2013a). In peritoneal
macrophages, cell fusion normally follows cytokine activation,
but the process is severely impaired if the leukocytes are harvested
from P2X7R−/− or Panx1−/− mice (Lemaire et al., 2011). Also,
monocyte-recruiting “find-me” signals are released by apoptotic
cells when the C-terminal tail of Panx1 channels are cleaved by
caspases 3 or caspase 7, so infiltration of infected/damaged tissue
by immune cells is slower when Panx1 is removed (Chekeni et al.,
2010; Qu et al., 2011). A model that takes into account our cur-
rent understanding of the induced innate immune response and
Panx1 activity is illustrated in Figure 2.
Autoimmunity is an example of inappropriate inflammation
becoming pathological, and here too Panx1 has been implicated.
Experimental autoimmune encephalomyelitis (EAE) is a com-
mon model of multiple sclerosis, which is a neurodegenerative
condition that stems from overactive leukocyte diapedesis into the
myelinated regions of the CNS. Panx1 expression tends to increase
in areas affected by EAE, and Panx1−/− mice experience a delay
in symptom onset that correlates well with delayed immune cell
infiltration (Lutz et al., 2013; Negoro et al., 2013). It should be
noted that the mechanism behind chemotaxis itself is not nec-
essarily dependent on Panx1, because a gradient of complement
component 5a is still equally attractive to knockout macrophages
(Kronlage et al., 2010).
Macrophages are not the only class of leukocyte functionally
modulated by Panx1. In neutrophils, for example, Panx1 appears
to be part of a protein complex that includes formyl-peptide
receptors, human tweety homolog 3, P2Y2R, and actin, that is
enriched at the leading edge during mobilization in response to
formyl-peptides released from ruptured host cells and/or invad-
ing bacteria (Chen et al., 2010). Formyl-peptide induced chemo-
taxis is completely disrupted if neutrophils are treated with CBX
or 10Panx1, presumably due to a loss of purinergic signaling cas-
cades at both the leading and trailing edge of the cells (acting
through P2Y2R and A2A receptors respectively) (Bao et al., 2013).
Lymphocytes are also affected by Panx1, such as during times of
hypertonic stress when T-cells are activated to form an “immune
synapse.” Panx1 co-localizes with P2X1R and P2X4R at these
immune synapses (Woehrle et al., 2010a), and pharmacologi-
cal blockers of the channel disrupts immune priming (Woehrle
et al., 2010b). IL-2 synthesis, calcium intake from the extracellular
space, and proliferation in response to T-cell receptor-mediated
MAPK activation are all impaired by pharmacological inhibition
of Panx1 (Schenk et al., 2008; Woehrle et al., 2010a). To our
knowledge, Panx2 and Panx3 expression has not been reported
in any type of immune cell, and their absence has been explicitly
verified in macrophages (Hanley et al., 2012).
Certain non-immune cell types also modulate immune
response during times of stress and, again, correlations with
Panx1 expression/activity have been reported. Gingival epithelial
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FIGURE 2 | The role of Panx1 in induced innate immunity. When an
invading microbe breaches an epithelial barrier, microbe-associated molecular
patterns (MAMPs) are recognized by phagocytic cells [e.g., lipopolysaccharide
(LPS) binding to toll-like receptors (TLR)], leading to an activation of the NF-κB
signaling cascade which up-regulates expression of the inflammasome
component NLRP3, pro-IL-1β, and TNFα. Inflammasome assembly brings
NLRP3 and pro-caspase1 together, using the adaptor protein ASC, and the
whole complex associates with P2X7R. If extracellular ATP levels become
elevated because of cellular distress in the vicinity (i.e., a “danger signal”),
P2X7R activation allows calcium to flow into the cell and potassium to flow
out-of the cell, along their respective concentration gradients. Lower
intracellular potassium is correlated with inflammasome activation, leading to
processing of pro-caspase1 into its active state. Panx1 is held in close
proximity to P2X7R because of an interaction with residue P451 on the
C-terminal end of the receptor, allowing local increases in extracellular
potassium and intracellular calcium to stimulate channel opening, thus
releasing more ATP into the extracellular space. This ATP further stimulates
P2X receptors in the surrounding area, but also inhibits Panx1 channels as a
negative feedback mechanism, preventing complete collapse of the
electrochemical gradient. Meanwhile, liberated caspase1 will cleave the
pro-peptide from IL-1β, which is then secreted from the cell along with TNFα.
Receptors for both of these cytokines (e.g., IL-1R and TNFR) are also
pro-inflammatory, and upon activation will initiate or perpetuate NF-κB
signaling. In addition, TNFR will induce the pro-apoptotic cascade that leads
to caspase3 and caspase7 activation; both can clip the C-terminal tail of
Panx1, which leads to a constitutively open channel. Several graphics
included in this figure were derived from works deposited in the Wikimedia
Commons (http://commons.wikimedia.org) by the following authors: LPS, by
Mike Jones; DNA, by Sponk; background eukaryotic cell, by Mariana Ruiz;
and mitochondria, by Kelvin Song.
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cells are the first line of defense in the oral cavity, where ATP stim-
ulated NLRP3 inflammasome activation leads to reactive oxygen
(ROS) formation and release; treating these cells with shRNA
against P2X7R, P2X4R, or Panx1 all reduce ROS by 50–75%,
and probenecid interferes with IL-1β release (Hung et al., 2013).
Lipopolysaccharide or chronic exposure to dietary saturated fatty
acids increases expression of panx1 and inflammasome com-
ponents in hepatocytes, which primes them for IL-1β release
and ATP-dependent apoptosis (Csak et al., 2011; Ganz et al.,
2011; Xiao et al., 2012). Similarly, neurons are highly sensitive to
apoptosis following inflammation, and Panx1 has been linked to
neuronal activation of the NLRP1 inflammasome in response to
hyperglycemia (Meng et al., 2013) and the AIM inflammasome
following exposure to double stranded DNA (Adamczak et al.,
2014).
Microbial infection
While significant effort has been devoted toward describing how
Panxs are involved in the host inflammatory response, a small
amount of work has also revealed how Panx can be hijacked
by invading pathogens. For example, the severity of erythrocyte
lysis following exposure to α-toxins from haemolytic E. coli or
S. aureus is reduced by CBX, mefloquine, or probenecid (Skals
et al., 2009, 2011). Assuming these inhibitors are effective due to
their ability to block Panx1 channels (the only Panx expressed
in red blood cells), then their influence over haemolytic infec-
tion could once again relate back to ATP release and activation
of a purinergic signaling cascade, because the α-toxin is unable
to integrate into the plasma membrane without P2X receptor
activation (Skals et al., 2009).
ATP signaling has also been implicated in the early phase of
HIV infection, somehow contributing to viral uptake by CD4+
host cells (Seror et al., 2011). Panx1 is translocated to areas of con-
tact between viral env-containing and CD4/CXCR4-containing
membranes, and blocking its activity with mimetic peptide or
siRNA substantially decreases the amount of new virus even-
tually produced by lymphocytes exposed to purified HIV par-
ticles (Seror et al., 2011; Orellana et al., 2013b; Paoletti et al.,
2013). Common Panx blockers like probenecid and mefloquine
are already used to treat human disease (Iglesias et al., 2008;
Silverman et al., 2008), so an in vivo study is hopefully on the
horizon; it will be interesting to see if these drugs have a place in
the current anti-retroviral cocktails administered to HIV patients,
or perhaps as prophylactics.
Response to O2 and vascular tone
Following the observation of Panx1 in the membrane of red
blood cells, questions were raised about the impact the chan-
nel might have on biochemical and autonomic responses to low
oxygen (Locovei et al., 2006a). ATP is released from erythrocytes
when they encounter an area with reduced O2, and this release
is sensitive to CBX, probenecid, and the 10Panx1 mimetic pep-
tide (Sridharan et al., 2010). An interaction between ATP and
P2Y receptors and/or P2X7R on the surface of erythrocytes could
stimulate even greater movement of ATP out of the cell, along
with release of epoxyeicosatrienoic acids (Locovei et al., 2006a;
Jiang et al., 2007), leading to activation of receptors on the blood
vessel walls. Purines are potent vasodilators when bound to P2Y
receptors on vascular endothelium (Burnstock, 2010), so the final
result is a widening of blood vessels and greater perfusion of
tissue experiencing low oxygen tension (Locovei et al., 2006a).
As previously discussed, however, the physiological context that
Panx1 finds itself can be an important factor in its downstream
effects. ATP is not always vasodilatory, as binding to P2X and
P2Y receptors in smoothmuscle cells generally causes contraction
(Burnstock, 2010). Phenylephrine induced vasoconstriction in
the thoracodorsal artery is inhibited by mefloquine, probenecid,
and Panx1 siRNA, similar to the effects of blocking P2Y recep-
tors directly (Billaud et al., 2011). It bares repeating, of course,
that not all ATP release is dependent on Panx1 channels; in the
case of erythrocytes, activation of the β-adrenergic prostacyclin
receptor allows ATP to exit the cell regardless of Panx channel
activity (Sridharan et al., 2012), while ATP outflow is only cut
by about half in Panx1−/− cells (or in wild-type cells treated with
probenecid/CBX) following exposure to the wasp venom protein
MST7 (Leal Denis et al., 2013).
Panxs may also play a more systemic role in monitor-
ing and responding to blood O2 levels. The carotid body is
a small structure (near the bifurcation of the carotid artery)
that encourages rapid breathing during hypoxia by sending
action potentials to the cardiorespiratory centers of the brain-
stem. Panx1 is expressed in the sustentacular (glomus type-II)
cells of the carotid body and is thought to amplify an exci-
tatory ATP signal following P2Y2 receptor activation, leading
to increased autonomic ventilation rate (Zhang et al., 2012b).
Panx1 is also expressed in the glossopharyngeal nerve (GPN)
that transmits signals from the carotid body to the brainstem,
and it has been proposed that depolarization induced opening
of the channels could release ATP, which drives a positive feed-
back to coordinate activity among the neurons within the fiber
(Campanucci et al., 2012).
Taste response
In taste buds, the gustatory receptor (type II) cells do not form
synapses with the afferent nerves responsible for transmitting
information to the brain, but instead are associated with sero-
tonergic presynaptic (type III) cells. ATP is released from tastant
activated receptor cells, which then activates P2X2R and P2X3R
on the presynaptic cell to induce neurotransmitter release into the
excitatory synapse (Finger et al., 2005). There is currently discord
in the literature as to how ATP is released from the receptor cells,
with one group claiming Panx1 channels are responsible (Huang
et al., 2007; Dando and Roper, 2009; Murata et al., 2010), while
another believes that Cx hemichannels are the primary route
(Romanov et al., 2007, 2008). Until very recently, both groups
relied exclusively on pharmacological methods to support their
positions. The evidence initially appeared to favor Panx1, but taste
buds harvested from Panx1−/− mice and depolarized by extracel-
lular K+ still activated ATP-biosensor cells held in close proximity
(Romanov et al., 2012); this work tells us that Panx1 channels are
not the only means of ATP release, although it leaves open the
possibility of an additive or redundant mechanism. CALHM1 is
an ion channel with many structural similarities to Panxs (Siebert
et al., 2013) that may play the part of primary ATP channel in
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type II cells, as cultures taken from Calhm1−/− mice suffer a loss
of taste-evoked ATP release (reviewed in Taruno et al., 2013).
Vision
Hydrostatic pressure is an important parameter in eye physi-
ology, one that must be tightly controlled to prevent disorders
like glaucoma. When the retina experiences a rise in hydrostatic
pressure, ATP is released in a CBX-sensitive fashion (Reigada
et al., 2008), and the subsequent activation of purinergic receptors
can be detrimental to neuronal health (Resta et al., 2007). Such
pressure can arise when there is an imbalance between aqueous
humor production by the ciliary body and outflow through the
trabecular meshwork. Inflow and outflow are both regulated by
extracellular ATP, and pharmacological studies implicate Panx1
and Cx43/40 hemichannels as being about equally important in
its release from intracellular stores (Li et al., 2010, 2012a). In
the lens, hyposmotic stress also causes probenecid-sensitive ATP
release, and the downstream signaling leads to elevated Na,K-
ATPase activity; the purpose of this effect is presumably to miti-
gate cell swelling by balancing osmotic driving force (Shahidullah
et al., 2012).
In addition to the homeostatic roles Panx1 may play in the
eye, it also modulates neuronal activity in the optic tectum (OT)
and retina. Using zebrafish larvae, Li et al. (2012b) illustrated how
repetitive depolarization of OT neurons stimulates Panx1 channel
activity, and the resultant release of chemo-attractants (proba-
bly ATP) recruits microglial processes to these over-active cells.
Bulbous contacts form between the neural soma and microglial
process, and through an ill-defined mechanism, spontaneous and
visually evoked neuronal activity is suppressed; put another way,
the neuron is encouraged to “take a rest” (Li et al., 2012b). In
terms of direct light perception by the retina, Panx1−/− mice
experience an elevated response amplitude to light inputs fol-
lowing dark conditioning, thus reducing the resolving power of
rod cell receptive fields (Kranz et al., 2013). This inability to see
as well in the dark is an excellent example of a phenotype not
immediately obvious in a laboratory setting, but would confer a
significant disadvantage in the wild.
DISCUSSION AND CONCLUDING REMARKS
More than 13 years have passed since the name “pannexin” was
first coined following the revelation that Inxs are represented
in chordate lineages, and the subsequent attention directed at
these molecules has been very exciting. The channels themselves
appear to have largely relinquished their ability to form intercel-
lular gap junctions—a function now performed by the Cxs—and
exist instead as large aqueous pores that facilitate communica-
tion between the intracellular and extracellular compartments.
Significant inroads have been made toward understanding the
biophysical properties of these pores, although the field remains
splintered over contradictory reports and thirsty for a com-
prehensive study to reconcile the differences, particularly with
respect to channel selectivity and unitary conductance. We also
eagerly await the publication of a Panx crystal structure, which
would either confirm the collective assumption that Panxs and
Cxs are structurally analogous or spark amassive upheaval should
something unexpected be observed.
Most cell types express at least one Panx paralog, and the bio-
logical impact these channels are claimed to have is as varied
and complex as the biological impacts of the ions and molecules
they are permeable to. Quite contrary to this seemingly broad
importance, however, is the relative innocuousness of systemi-
cally blocking activity or completely knocking out Panxs in mice.
Does sufficient redundancy exist to compensate when Panxs are
removed from the system, and if so, what are those mechanisms?
Furthermore, how can such redundancies be retained when evo-
lutionary forces usually conspire to retool or remove biological
components with overlapping function? Or perhaps Panx activity
is only really important during times of stress or disease, so mice
in a controlled laboratory setting do not experience fitness deficits
if Panx is absent. We must also be cautious of flawed pharmaco-
logical inhibitors, which may have led some investigations astray
with unforeseen off-target effects. Fortunately, the availability of
knockout animals is becoming less of a limiting factor, so these
issues will most certainly continue to resolve over the near term.
The pace of Panx research does not appear to be waning and, as
we continue to observe these enigmatic channel proteins, they will
undoubtedly continue to be implicated in an even greater number
of biological processes. One thing to remain mindful of, however,
is that the Panxs are not likely to be the “cause” of most of them—
at least not in the same sense that enzymes or transcription factors
“cause” biological processes. Panxs should be thought of more
generally as “enablers,” helping to propagate or amplify signaling
cascades across membranes. Assessing the effects of Panx from
this perspective could help protect against over-interpretation
of experimental outcomes, and will hopefully encourage a more
rigorous exploration of alternative or downstream mechanisms.
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